Tuico, Sheilah Mae .

HRN: 19-71-83  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2026
CO-AMOXICLAV 625MG (TAB)
04/07/2026
04/13/2026
ORAL
625
BID
UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractFebrile Neutropenia    Compliance to guidelines: Compliant To Guidelines